Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c

May 14, 2025 6:16 PM EDT

Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).

For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Citi, Earnings, Maynard Um, Mark Zuckerberg, ARK